AMCP eLearning DAYS are virtual days of education featuring the hottest topics in managed care, including: Digital Therapeutics: Understanding the Emerging Product Class; Drug Pipeline: Traditional Pharmaceuticals and Biosimilars; Health Policy Trends Impacting Managed Care Pharmacy; and Pharmaceutical Marketplace Trends.
Dr. Michael Grabner, Senior Research Scientist for HealthCore, presents a poster entitled, “Economic Burden of Acute Steroid-Refractory Graft Versus Host Disease (GVHD) in Commercially Insured Pediatric Patients”. This presentation reports findings from one of the first studies that estimated cost burden associated with SR aGVHD following stem cell transplants. The study used administrative claims from a large national US payor between 2006 and 2019. A total of 38 patients with SR aGVHD and 184 controls were included (mean age ~8 years, ~50% female in both cohorts). Over 12 months follow-up, the SR aGVHD cohort more frequently experienced complications (e.g. GI manifestations 95% vs. 65%) and hospital readmissions (89% vs 60%), contributing to higher direct medical costs ($1.2m vs $670k).
For questions about this presentation, please contact Dr. Grabner at moc.erochtlaeh@renbargm.